The National Blood Authority (NBA) has recently completed tender processes for the supply of several blood products. The following information is important for people who are currently treated with recombinant factor VIII for haemophilia A:
Imported Plasma & Recombinant Product Tender Outcomes – Frequently asked questions (FAQs) for patients
http://www.nba.gov.au/supply/iprp-tender-faqs-patient.pdf
More information on the tender outcomes can be found on the NBA web site: